Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SAN FRANCISCO, Sept. 25, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in Forterra, Inc. (NASDAQ:FRTA) of the October 13, 2017 Lead Plaintiff deadline in the pending securities class action.
If you purchased or otherwise acquired common stock of Forterra pursuant and/or traceable to the Company’s initial public offering on or about October 21, 2016 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/FRTA
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On or about October 21, 2016 Defendants priced the Company’s initial public offering (“IPO”) for the issuance of 18.42 million shares at $18.00 per share. Since then, the price of Forterra shares has fallen to as low as $4.23 per share on September 21, 2017.
The lawsuit alleges that the IPO Registration Statement and Prospectus omitted disclosures of information that reasonable investors would consider important such as failure to accrue expenses leading up to the IPO and material weaknesses in internal controls relating to “bill-and-hold” revenue transactions.
Recently, on September 6, 2017, Forterra’s CFO (Matt Brown) resigned effective immediately.
“Among other things, we’re focused on are the Defendants’ omissions from the IPO Prospectus that appear to have wiped out 75% of shareholder value since late October 2016,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding Forterra should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 11 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000
